/IBEX

Ibex Ltd

IBEX

$39.80USD↑+6.82%+2.54 today

MARKET CAP

532.9M

P/E (TTM)

12.4x

FWD P/E

—

DAY RANGE

$32 – $40

52W RANGE

$26

$43

AI Summary

Stalk

StalkMedium

IBEX remains in an early Stage 1 consolidation within a long-term uptrend. Price has repaired its 9/21 EMA regime and is range-bound, suggesting cautious accumulation. Medium-term directional bias is modestly bullish, but short-term timing is neutral, warranting deferred execution into pullbacks around EMA support.

↑Q3 FY26 revenue $164.4M (+17% YoY); adjusted EPS $0.91 (+11% YoY).
↑Health tech vertical revenue +54% YoY drives high margins.
↓Capital expenditures rising to $25–30M could pressure margins.

Full analysis →

Buying

2

institutions

Selling

7

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.04 M	31.45 M	+75.73 K	+22.2%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	299.22 K	9.02 M	+-41.19 K	-1.1%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	207.65 K	6.31 M	+-9.11 K	+8.5%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	78.59 K	2.39 M	+2.07 K	+16.3%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	58.91 K	1.79 M	+-47.41 K	-37.3%	0.00%
MG Man Group Plc Q2 2026	SELL	18.06 K	548.48 K	+-102.25 K	-83.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	14.70 K	446.53 K	+-76.59 K	-81.8%	0.00%
GM Grantham, Mayo, Van Otterloo & Co. LLC Q2 2026	SELL	6.88 K	209.01 K	+-3.83 K	-27.3%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	610.00	18.53 K	+-680.00	-46.5%	0.00%